XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · Real-Time Price · USD
0.469
+0.034 (7.75%)
At close: Mar 6, 2026, 4:00 PM EST
0.466
-0.002 (-0.51%)
After-hours: Mar 6, 2026, 7:45 PM EST
XORTX Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| Selling, General & Admin | 1.83 | 2.19 | 2.28 | 1.93 | 1.22 | |
| Research & Development | 0.57 | 0.18 | 2.42 | 6.76 | 0.68 | |
| Amortization of Goodwill & Intangibles | 0.03 | 0.03 | 0.07 | 0.02 | 0.01 | |
| Operating Expenses | 2.54 | 2.62 | 4.96 | 9.24 | 2.31 | |
| Operating Income | -2.54 | -2.62 | -4.96 | -9.24 | -2.31 | |
| Interest Expense | - | - | - | - | -0 | |
| Interest & Investment Income | 0.04 | 0.12 | 0.25 | 0.1 | - | |
| Currency Exchange Gain (Loss) | -0 | -0.07 | -0.01 | -0 | -0.01 | |
| Other Non Operating Income (Expenses) | -0.15 | -0.75 | 2.55 | 1.42 | 0.75 | |
| EBT Excluding Unusual Items | -2.65 | -3.31 | -2.16 | -7.72 | -1.58 | |
| Asset Writedown | -0 | - | - | - | - | |
| Pretax Income | -2.66 | -3.31 | -2.16 | -7.72 | -1.58 | |
| Net Income | -2.66 | -3.31 | -2.16 | -7.72 | -1.58 | |
| Net Income to Common | -2.66 | -3.31 | -2.16 | -7.72 | -1.58 | |
| Shares Outstanding (Basic) | 5 | 3 | 2 | 1 | 1 | |
| Shares Outstanding (Diluted) | 5 | 3 | 2 | 1 | 1 | |
| Shares Change (YoY) | 64.48% | 45.25% | 33.91% | 35.25% | 47.77% | |
| EPS (Basic) | -0.56 | -1.15 | -1.09 | -5.22 | -1.44 | |
| EPS (Diluted) | -0.56 | -1.15 | -1.09 | -5.22 | -1.44 | |
| Free Cash Flow | -2.77 | -3.68 | -6.59 | -8.19 | -4.8 | |
| Free Cash Flow Per Share | -0.58 | -1.28 | -3.32 | -5.53 | -4.39 | |
| EBITDA | -2.43 | -2.58 | -4.88 | -9.22 | -2.3 | |
| D&A For EBITDA | 0.11 | 0.04 | 0.07 | 0.02 | 0.01 | |
| EBIT | -2.54 | -2.62 | -4.96 | -9.24 | -2.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.